Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 6/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | FABP3 | P05413 | 1/20 | 0.31 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24825118 | 1.00 | GLP1R (0.39) | GLP1RSMN1; SMN2FABP3FABP4FABP5 | |
| SCHEMBL30164985 | 0.91 | SMN1; SMN2 (0.34) | GLP1RSMN1; SMN2 | |
| SCHEMBL29206744 | 0.78 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL23578775 | 0.76 | LMNA (0.33) | — | |
| SCHEMBL24826762 | 0.75 | LMNA (0.36) | — | |
| SCHEMBL24826757 | 0.73 | LMNA (0.32) | — | |
| SCHEMBL30164827 | 0.73 | LMNA (0.32) | — | |
| SCHEMBL16849135 | 0.73 | L3MBTL1 (0.40) | GLP1RSMN1; SMN2FABP3FABP4FABP5 | |
| SCHEMBL24811598 | 0.73 | KCNJ5 (0.37) | — | |
| SCHEMBL30865601 | 0.73 | KCNJ5 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117858872-A | Heterocyclic EGFR inhibitors for the treatment of cancer | 缆图药品公司 | 2024-04-09 | — | — | CN | disclosed |